Chemical Works of Gedeon Richter Plc Logo

Chemical Works of Gedeon Richter Plc

Develops and manufactures drugs for women's health, CNS, and cardiovascular diseases.

RICHT | BUD

Overview

Corporate Details

ISIN(s):
HU0000067624 (+3 more)
LEI:
549300J6ZJW5IH4WEE46
Country:
Hungary
Address:
GYOMROI UT 19-21, 1103 BUDAPEST
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Chemical Works of Gedeon Richter Plc. is a multinational, vertically integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of medicinal products. The company's core therapeutic areas include women's health, central nervous system disorders, and cardiovascular diseases, with additional activity in oncology. Its portfolio consists of original research drugs, active pharmaceutical ingredients (APIs), and generic medicines. Founded in 1901, Gedeon Richter focuses on delivering high-value therapies to improve the quality of life for patients globally.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-27 08:59
Transaction in Own Shares
Transactions with Treasury Shares
Hungarian 226.8 KB
2025-11-27 08:59
Transaction in Own Shares
Transactions with Treasury Shares
English 321.4 KB
2025-11-26 09:12
Transaction in Own Shares
Transactions with Treasury Shares
Hungarian 192.9 KB
2025-11-26 09:12
Transaction in Own Shares
Transactions with Treasury Shares
English 295.6 KB
2025-11-25 09:03
Transaction in Own Shares
Transactions with Treasury Shares
Hungarian 229.2 KB
2025-11-25 09:03
Transaction in Own Shares
Transactions with Treasury Shares
English 199.8 KB
2025-11-06 12:59
Related Party Transaction
Subsidiaries transactions Q1-Q3 2025
English 179.1 KB
2025-11-06 12:59
Related Party Transaction
Subsidiaries transactions Q1-Q3 2025
Hungarian 238.5 KB
2025-11-06 06:03
Investor Presentation
edeon Richter Plc. - Company presentation Q3 2025
Hungarian 1.4 MB
2025-11-06 06:03
Investor Presentation
edeon Richter Plc. - Company presentation Q3 2025
English 1.4 MB
2025-10-31 14:11
Regulatory News Service
Voting rights, registered capital
Hungarian 244.7 KB
2025-10-31 14:11
Declaration of Voting Results & Voting Rights Announcements
Voting rights, registered capital
English 207.0 KB
2025-10-09 10:32
Regulatory News Service
Half-year report for the period ended 30 June 2025 published on August 6, 2025…
Hungarian 1.4 MB
2025-10-09 10:32
Interim Report
Half-year report for the period ended 30 June 2025 published on August 6, 2025…
English 1.4 MB
2025-09-30 14:34
Declaration of Voting Results & Voting Rights Announcements
Voting rights, registered capital
Hungarian 243.0 KB

Automate Your Workflow. Get a real-time feed of all Chemical Works of Gedeon Richter Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Chemical Works of Gedeon Richter Plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Chemical Works of Gedeon Richter Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Tourmaline Bio, Inc. Logo
Develops an anti-IL-6 antibody for cardiovascular, inflammatory, and immune diseases.
United States of America
TRML
TOWA PHARMACEUTICAL CO.,LTD. Logo
Manufactures and markets high-quality, accessible generic drugs for various therapeutic areas.
Japan
4553
Transcode Therapeutics, Inc. Logo
Develops targeted RNA therapies for metastatic cancer using a proprietary nanoparticle delivery platform.
United States of America
RNAZ
Travere Therapeutics, Inc. Logo
Develops therapies for rare kidney and metabolic diseases, with an FDA-approved treatment for IgA nephropathy.
United States of America
TVTX
Traws Pharma, Inc. Logo
Develops oral small-molecule therapies for respiratory viral diseases and cancer.
United States of America
TRAW
TScan Therapeutics, Inc. Logo
Developing TCR-engineered T-cell therapies for solid and hematologic cancers.
United States of America
TCRX
TSUMURA & CO. Logo
A leader in Japanese Kampo herbal medicine, producing prescription and OTC formulations.
Japan
4540
TuHURA Biosciences, Inc./NV Logo
Phase 3 immuno-oncology firm developing therapeutics to overcome cancer therapy resistance.
United States of America
HURA
TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo
Turkish producer of pharmaceuticals, specializing in IV solutions and vaccines for hospitals.
Türkiye
TRILC
Tvardi Therapeutics, Inc. Logo
Developing oral STAT3 inhibitors to treat cancers and fibrosis-driven diseases.
United States of America
TVRD

Talk to a Data Expert

Have a question? We'll get back to you promptly.